Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumors (NSGCT): Efficacy results of phase II trial.

A. Tryakin,Mikhail Fedyanin,U. Sergeev,Anatoly Bulanov,Bahrom Ahmedov,T. Zakharova,A. Mitin,I. Fainstein,A. Garin,Sergei Tjulandin

Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumors (NSGCT): Efficacy results of phase II trial.

2015

A. Tryakin
Mikhail Fedyanin
U. Sergeev
Anatoly Bulanov
Bahrom Ahmedov
T. Zakharova
A. Mitin
I. Fainstein
A. Garin
Sergei Tjulandin

e15566 Background: Three-weekly BEP has been a standard of chemotherapy of advanced NSGCT for last two decades. We performed a phase II study to assess the efficacy and toxicity of two-weekly aBEP ...

Keywords:

Germ cell tumors
Oncology
Regimen
Pathology
Induction chemotherapy
Internal medicine
Medicine
Phases of clinical research
poor prognosis
Toxicity
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations